Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$10.18
-1.0%
$9.40
$6.82
$23.29
$1.57B0.852.98 million shs2.79 million shs
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$78.87
-0.8%
$88.08
$78.27
$118.01
$1.80B0.5278,862 shs399,365 shs
NovoCure Limited stock logo
NVCR
NovoCure
$16.69
-0.2%
$16.75
$9.82
$21.45
$1.94B1.011.68 million shs1.15 million shs
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$22.20
-1.6%
$25.47
$13.39
$37.77
$502.83M0.8318,549 shs433,690 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-2.10%+16.29%+7.87%+16.69%-30.07%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
-1.13%+0.85%-2.51%-15.41%-13.72%
NovoCure Limited stock logo
NVCR
NovoCure
+3.08%+8.93%-3.02%+17.09%+31.76%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
+1.76%+1.08%-5.41%-15.25%+64.67%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$10.18
-1.0%
$9.40
$6.82
$23.29
$1.57B0.852.98 million shs2.79 million shs
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$78.87
-0.8%
$88.08
$78.27
$118.01
$1.80B0.5278,862 shs399,365 shs
NovoCure Limited stock logo
NVCR
NovoCure
$16.69
-0.2%
$16.75
$9.82
$21.45
$1.94B1.011.68 million shs1.15 million shs
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$22.20
-1.6%
$25.47
$13.39
$37.77
$502.83M0.8318,549 shs433,690 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-2.10%+16.29%+7.87%+16.69%-30.07%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
-1.13%+0.85%-2.51%-15.41%-13.72%
NovoCure Limited stock logo
NVCR
NovoCure
+3.08%+8.93%-3.02%+17.09%+31.76%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
+1.76%+1.08%-5.41%-15.25%+64.67%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
2.80
Moderate Buy$17.4070.92% Upside
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
2.33
Hold$110.6040.23% Upside
NovoCure Limited stock logo
NVCR
NovoCure
2.14
Hold$21.2027.02% Upside
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.67
Moderate Buy$38.4072.97% Upside

Current Analyst Ratings Breakdown

Latest TCMD, NVCR, LMAT, and ATEC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/14/2026
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
UpgradeHold (C)Hold (C+)
8/31/2026
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
DowngradeHold (C+)Hold (C)
8/27/2026
NovoCure Limited stock logo
NVCR
NovoCure
Reiterated RatingSell (D-)
8/17/2026
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
UpgradeHold (C-)Hold (C+)
8/14/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
DowngradeBuy (B-)Hold (C+)
8/11/2026
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
Lower Price TargetBuy$40.00 ➝ $39.00
8/5/2026
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Boost Price TargetBuy$11.00 ➝ $13.00
8/5/2026
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Boost Price TargetBuy$15.00 ➝ $16.00
8/5/2026
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Boost Price TargetOutperform$11.00 ➝ $12.00
8/5/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
Lower Price TargetEqual Weight$104.00 ➝ $94.00
8/5/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
DowngradeOutperformMarket Perform
(Data available from 9/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$815.05M1.93N/AN/A$0.08 per share127.25
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$262.43M6.87$2.85 per share27.70$17.35 per share4.55
NovoCure Limited stock logo
NVCR
NovoCure
$699.19M2.78N/AN/A$3.04 per share5.49
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$329.52M1.53$1.15 per share19.25$9.80 per share2.27
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-$143.36M-$0.71N/A339.33N/A-13.49%-6,752.24%-13.88%10/29/2026 (Estimated)
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$57.73M$2.8527.6724.882.3225.02%15.63%10.06%11/5/2026 (Estimated)
NovoCure Limited stock logo
NVCR
NovoCure
-$136.23M-$1.30N/AN/AN/A-21.25%-44.00%-15.85%10/29/2026 (Estimated)
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$19.09M$1.0820.5616.44N/A7.10%11.49%9.17%11/2/2026 (Estimated)

Latest TCMD, NVCR, LMAT, and ATEC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/10/2026Q2 2026
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$0.1350$0.34+$0.2050$0.34$85.52 million$85.70 million
8/4/2026Q2 2026
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$0.07$0.07N/A-$0.16$211.26 million$213.51 million
8/4/2026Q2 2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$0.8070$0.74-$0.0670$0.74$71.47 million$70.38 million
7/23/2026Q2 2026
NovoCure Limited stock logo
NVCR
NovoCure
-$0.3315-$0.13+$0.2015-$0.13$172.44 million$183.58 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
N/AN/AN/AN/AN/A
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$1.001.27%+16.05%35.09%14 Years
NovoCure Limited stock logo
NVCR
NovoCure
N/AN/AN/AN/AN/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
N/AN/AN/AN/AN/A

Latest TCMD, NVCR, LMAT, and ATEC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/28/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
quarterly$0.251.21%8/20/20268/20/20269/3/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
40.35
1.89
1.07
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
0.40
16.31
13.96
NovoCure Limited stock logo
NVCR
NovoCure
0.58
2.89
2.70
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
N/A
4.12
3.68

Institutional Ownership

CompanyInstitutional Ownership
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
66.35%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
84.64%
NovoCure Limited stock logo
NVCR
NovoCure
84.61%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
83.43%

Insider Ownership

CompanyInsider Ownership
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
13.48%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
7.40%
NovoCure Limited stock logo
NVCR
NovoCure
6.55%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
913154.45 million133.63 millionOptionable
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
65522.87 million21.18 millionOptionable
NovoCure Limited stock logo
NVCR
NovoCure
1,605116.45 million108.82 millionOptionable
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
1,08622.65 million22.18 millionOptionable

Recent News About These Companies

Tactile Systems Technology : TCMD

New MarketBeat Followers Over Time

Media Sentiment Over Time

Alphatec stock logo

Alphatec NASDAQ:ATEC

$10.18 -0.10 (-0.97%)
Closing price 04:00 PM Eastern
Extended Trading
$10.18 0.00 (-0.05%)
As of 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

LeMaitre Vascular stock logo

LeMaitre Vascular NASDAQ:LMAT

$78.87 -0.60 (-0.76%)
Closing price 04:00 PM Eastern
Extended Trading
$78.86 -0.02 (-0.02%)
As of 04:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

NovoCure stock logo

NovoCure NASDAQ:NVCR

$16.69 -0.03 (-0.18%)
Closing price 04:00 PM Eastern
Extended Trading
$16.70 +0.00 (+0.03%)
As of 04:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Tactile Systems Technology stock logo

Tactile Systems Technology NASDAQ:TCMD

$22.20 -0.36 (-1.60%)
Closing price 04:00 PM Eastern
Extended Trading
$22.17 -0.03 (-0.14%)
As of 05:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.